Celebrating 30 years, Taiwan’s National Health Insurance is hailed globally for health equity and access—but rising costs and delayed drug access now pose serious sustainability challenges.
Taoyuan Hub One blends smart retail technology with local culture, featuring vending machines that showcase iconic Taoyuan snacks and Hakka-themed goods, offering residents and visitors a flavorful glimpse into the city’s vibrant identity.
IDC’s 2024 AI Opportunity Study, sponsored by Microsoft, outlines five key trends shaping AI adoption worldwide—from rising generative AI ROI to growing demand for custom solutions and skilled talent. With insights from over 4,000 business leaders, the study highlights how organizations are unlocking value across industries.
Roche Taiwan is advancing personalized healthcare and driving medical innovation through strong public-private partnerships, sustainable practices, and a deep commitment to patient well-being. With pioneering work in diagnostics, oncology, and ophthalmology, the company continues to shape a healthier future for Taiwan.
Johnson & Johnson Taiwan is advancing healthcare through groundbreaking innovations in medicine and MedTech, while championing faster access, patient-centered care, and workforce development. From oncology and neuroscience to AI-powered surgery, the company is redefining what’s possible in Taiwan’s evolving healthcare landscape.
Under new leadership, Bayer Taiwan is strengthening its role as a bridge between advanced healthcare and sustainable food systems—fostering local partnerships, clinical trials, and regenerative farming to build a healthier future.
Merck Taiwan is deepening its role as a strategic innovation partner across semiconductors, biotech, and healthcare, backed by its largest-ever electronics investment and a bold push in AI, sustainability, and talent development.
In his 2025 letter to investors, BlackRock’s Larry Fink urges the investment industry to unlock private markets and reimagine diversification—making prosperity more inclusive in an era of growing inequality.
With groundbreaking therapies and deep collaboration across Taiwan’s healthcare system, Novartis Taiwan is driving innovation, advancing equity, and building a healthier future.
With its T-CaReMe Taipei Declaration, Taiwan is redefining chronic disease management through precision medicine, digital tools, and a system-wide push for early detection and tailored care.
